2023 International Congress Archives - Page 132 of 186

Placebo response in Parkinson’s disease (PD) is predicted by expression levels of a specific brain network

J. Barbero, C. Tang, A. Vo, Y. Ma, S. Peng, B. Brakedal, C. Dölle, N. Brekke, C. Tzoulis, D. Eidelberg (Manhasset, USA)
Plasma biomarkers in iRBD patients serve as potential markers of early PD and motor severity

B. Huxford, C. Simonet-Hernandez, L. Pérez-Carbonell, A. Schrag, R. Dobson, A. Noyce (London, United Kingdom)
Plasma glucosylsphingosine in GBA1 E326K, N370S and L444P mutation carriers with and without Parkinson’s disease

A. Haimovich, J. Agin-Liebes, N. Hatcher, L. Yao, C. Waters, R. Alcalay (New York, USA)
POLR3A-Related Disorders and Response to Deep Brain Stimulation

WY. Yau, C. Ashton, E. Mulroy, T. Foltynie, P. Limousine, J. Vandrovcova, R. Stell, M. Davis, P. Lamont (Perth, Australia)
Polyaromatic hydrocarbons in Ambient Particulate Matter (PM 2.5) mediate neurodegeneration through the olfactory-brain axis in C57BL/6 mice

SR. Panda, VGM. Naidu (Guwahati, India)
Polyneuropathy in Parkinson’s disease: cross-sectional analysis of the Bochum Parkinson Nerve Study cohort

R. Scherbaum, L. Basner, L. Ortmann, J. Steininger, K. Müller, A. Bieber, P. Schülken, J. Motte, A. Fisse, T. Grüter, R. Gold, K. Pitarokoili, L. Tönges (Bochum, Germany)
Population-Scale Long-Read Sequencing to Catalog Structural Variants in Parkinson’s Disease

K. Billingsley (bethesda, USA)
Positive and negative myoclonus monitoring using ambulatory surface EMG and 3D accelerometry

S. Rissanen, A. Sinokki, J. Hyppönen, L. Säisänen, K. Silvennoinen, P. Karjalainen, E. Mervaala, Z. Hadj-Allal, R. Kälviäinen (Kuopio, Finland)
Post encephalitic dystonia-ataxia syndrome

A. Elavarasi, F. Mustafa, A. Garg, M. Tripathi, D. Vibha, R. Singh, B. Mishra (New Delhi, India)
Post stroke Restless Limb Syndrome and its impact on sleep and life quality in patients in Rural Gujarat, India

S. Desai, J. Darji, D. Desai (Anand, India)